Skip to main content
. 2021 Apr 29;48(11):3550–3559. doi: 10.1007/s00259-021-05348-6

Fig. 1.

Fig. 1

Consort diagram of patients from the PETAL and OPTIMAL>60 trials included in the bone marrow analysis